BioCentury
ARTICLE | Clinical News

Spectrum Pharmaceuticals preclinical data

April 25, 2005 7:00 AM UTC

In a rat model of breast cancer, SPI-1620 followed by paclitaxel significantly reduced the tumor volume compared to paclitaxel alone. The endothelin B agonist led to complete remission in 15% of rats ...